Historical award
Olink Proteomics Inc
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (16 days old).
Fiscal year 2026: data through (16 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $47,300.00
- Potential award value
- $47,300.00
- Total obligated to date
- $47,300.00
Source date: Nov 9, 2026
Recorded work
MYELODYSPLASTIC SYNDROMES ARE HETEROGENEOUS STEM CELL MALIGNANCIES CHARACTERIZED BY CHRONIC INFLAMMATION, PERIPHERAL CYTOPENIAS, AND BONE MARROW DYSPLASIA. LRBGE PRELIMINARY DATA FROM TARGETED PROTEOMIC ARRAYS HAS IDENTIFIED SUBSTANTIAL CHANGES IN TH
Award activity
- Obligations in covered fiscal years
- $47,300.00
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_75N98026P01085_7529_-NONE-_-NONE-